The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Skoberne, M.
Right arrow Articles by Geginat, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Skoberne, M.
Right arrow Articles by Geginat, G.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
The Journal of Immunology, 2002, 168: 1854-1860.
Copyright © 2002 by The American Association of Immunologists

Efficient In Vivo Presentation of Listeria monocytogenes- Derived CD4 and CD8 T Cell Epitopes in the Absence of IFN-{gamma}1

Mojca Skoberne and Gernot Geginat2

Institut für Medizinische Mikrobiologie und Hygiene, Fakultät für Klinische Medizin Mannheim der Universität Heidelberg, Mannheim, Germany


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
IFN-{gamma} is an essential component of the early Listeria monocytogenes-specific immune response, and is also an important regulator of Ag processing and presentation. Ag presentation is required for the induction and also the effector function of antimicrobial T cells. To evaluate the effect of IFN-{gamma} on bacterial Ag presentation in vivo, macrophages and dendritic cells were separated from L. monocytogenes-infected tissues and analyzed with peptide-specific CD4 and CD8 T cell lines in a sensitive ELISPOT-based ex vivo Ag presentation assay. The comparison of professional APCs isolated from infected IFN-{gamma}-deficient and wild-type mice revealed different peptide presentation patterns of L. monocytogenes-derived CD8 T cell epitopes, while the presentation pattern of CD4 T cell epitopes remained unchanged. The further in vitro analysis of the generation of CD8 T cell epitopes revealed a peptide-specific effect of IFN-{gamma} on MHC class I-restricted Ag presentation. These results show that despite this modulation of the Ag presentation pattern of CD8 T cell epitopes, IFN-{gamma} is not generally required for the MHC class I- and MHC class II-restricted presentation of L. monocytogenes-derived antigenic peptides by professional APCs in vivo.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Interferons are cytokines that play a central role in the resistance of mammalian hosts to pathogens. The type II IFN, IFN-{gamma}, is secreted by activated CD8 T cells, the Th1 subset of CD4 T cells, and by NK cells. The functions of IFN-{gamma} include the regulation of the Th cell response, the stimulation of the bactericidal activity of phagocytes, and the regulation of Ag presentation through class I and class II MHC molecules (1).

The resistance against the facultatively intracellular bacterium Listeria monocytogenes is IFN-{gamma} dependent. IFN-{gamma} is strongly secreted during the early T cell-independent phase of a primary L. monocytogenes infection (2). NK cells represent an important source of IFN-{gamma} during the early phase of the murine L. monocytogenes infection. Mice with a targeted disruption of the genes coding for IFN-{gamma} (GKO)3 (3) or the IFN-{gamma} receptor (RKO) (4) die after infection with a relatively low dose of L. monocytogenes. Generally, it is believed that the most important function of IFN-{gamma} during L. monocytogenes infection is the stimulation of the killing of bacteria in infected macrophages (5, 6, 7). For the T cell-dependent antilisterial immunity, IFN-{gamma} is not essential (3). Recently, the analysis of listeriolysin O (LLO)91–99- and p60217–225-specific CD8 T cells in wild-type (wt) and GKO mice revealed that also the relative immunodominance of antilisterial CD8 T cell populations is IFN-{gamma} dependent (8).

IFN-{gamma} is a potent regulator of Ag processing and presentation. Multiple essential components of the cytosolic Ag presentation pathway are subject to IFN-{gamma} regulation, e.g., the expression of TAP (9), the expression of proteasome subunits (10), and the expression of the MHC class I heavy chain and {beta}2-microglobulin genes (11). The cytosolic degradation of Ag is thought to be a function of the proteasome, in which three subunits, LMP2, LMP7, and multicatalytic endopeptidase complex-like 1, and also the PA 28 regulator are induced by IFN-{gamma} (reviewed in Ref. 10). IFN-{gamma} regulation of the endosomal Ag presentation pathway includes the expression of endosomal proteases (12, 13) and of MHC class II molecules (14).

To evaluate the effect of IFN-{gamma} on microbial Ag presentation in vivo, macrophages and dendritic cells (DC) were separated from L. monocytogenes-infected spleens and analyzed with peptide-specific CD4 and CD8 T cell lines using the recently developed, sensitive ELISPOT-based ex vivo Ag presentation assay (15). Our data show that despite IFN-{gamma} modulation of the Ag presentation pattern of CD8 T cell epitopes, IFN-{gamma} is not necessary for the efficient MHC class I- and MHC class II-restricted presentation of bacterial T cell epitopes by professional APC in vivo.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Mice and infection of mice

Female BALB/cOlaHsd (H-2d), C57BL/6 (H-2b), and SV129 (H-2b) mice were purchased (Harlan-Winkelmann, Borchen, Germany), kept under conventional conditions, and used at 8–10 wk of age. BALB/c mice with a targeted mutation of the gene coding for IFN-{gamma} (C.129S7(B6)-Ifngtm1Ts (16)) and 129-Ifngrtm1 mice (4) with a targeted mutation of the gene coding for the IFN-{gamma} receptor were obtained from The Jackson Laboratory (Bar Harbor, ME) and were bred under conventional conditions. Mice were infected with L. monocytogenes serovar 1/2a EGD in 0.2 ml PBS i.v., as indicated. Bacteria used for infection were in the logarithmic growth phase. The bacterial concentration was estimated from the OD600.

CD4 and CD8 T cell lines

CD8 T cell lines specific for p60217–225, p60449–457, p60476–484, and LLO91–99 were derived from spleens of L. monocytogenes-infected BALB/c mice. A Ld-restricted murine CMV pp89168–176-specific CD8 T cell line (17) was kindly provided by R. Holtappels (University of Mainz, Mainz, Germany). All CD8 T cell lines were propagated by repeated restimulation with P815 cells transfected with the human B7.1 gene (P815/B7) (18) in the presence of the appropriate synthetic peptide in medium supplemented with IL-2, as described previously (19). CD4 T cell lines specific for LLO190–201, LLO318–329, LLO253–264, and p60177–188 were established from spleens 14 days after i.v. infection of C57BL/6 mice with 1 x 103 CFU L. monocytogenes. CD4 T cell lines were repeatedly restimulated with mitomycin C-inactivated splenocytes as APC in the presence of 10-6 M peptide. The T cell culture medium was {alpha} modification of Eagle’s medium (Invitrogen, Karlsruhe, Germany) supplemented with glutamine, penicillin, streptomycin, 10% FCS, 100 U/ml murine rIL-2 (R&D Systems, Wiesbaden Germany), and 2 x 10-5 M 2-ME.

Immunomagnetic isolation and cytofluorometric analysis of macrophages and DC

Cells expressing CD11b or CD11c were isolated by immunomagnetic cell sorting from spleens of L. monocytogenes-infected mice. Cells were selected with paramagnetic microbeads conjugated to monoclonal hamster anti-mouse-CD11b (clone M1/70.15.11.5; Miltenyi Biotec, Bergisch Gladbach, Germany) and anti-mouse CD11c Abs (clone N418; Miltenyi Biotec), respectively. Spleens were removed 48 h after i.v. infection of mice. Spleens were injected with 500 µl of a 1 mg/ml solution of collagenase D (Roche Diagnostics, Mannheim, Germany) in HBSS. Subsequently, spleens were cut in small pieces and incubated 30 min at 37°C, 5% CO2 in the collagenase D buffer. Cells were collected by centrifugation and separated twice on MS+ positive selection columns (Miltenyi Biotec) following the standard positive selection protocol provided by the manufacturer. For each experiment, spleens from three mice were pooled. At the end of the positive selection procedure, between 0.5 x 106 and 2 x 106 positive cells were obtained per 1 x 108 spleen cells. Aliquots of the selected cells were stained with FITC-labeled rat anti-mouse CD11b IgG2b mAb (clone M1/70; BD PharMingen, San Diego, CA), rat Ig2b isotype control mAb (A95-1; BD PharMingen), hamster anti-mouse CD11c IgG mAb (clone HL3; BD PharMingen), and hamster IgG isotype control mAb (clone G235-2356; BD PharMingen), respectively, and subjected to FACS analysis. Cells selected with anti-CD11c microbeads were generally >80% pure DC. A differential cell count revealed that macrophage-like mononuclear cells selected by anti-CD11b microbeads were contaminated by approximately 30% polymorphonuclear granulocytes. For the analysis of MHC class I and II expression, isolated DC were stained with FITC-labeled hamster anti-mouse CD11c IgG mAb and PE-labeled rat anti-mouse I-A/I-E IgG2b mAb (clone M5/114.15.2; BD PharMingen) or with unlabeled rat anti-mouse MHC class I IgG2a mAb (clone ER-HR 52; Bachem/Peninsula Laboratories, San Carlos, CA), followed by PE-labeled goat anti-rat IgG mAb (Southern Biotechnology Associates, Birmingham, AL), respectively.

Isolation of endogenously processed peptides

Peptide extraction from infected cells and organs was performed as described previously (15). Briefly, spleens were removed 48 h after i.v. infection with 1 x 106 (BALB/c wt mice) or 1 x 104 (GKO mice) CFU L. monocytogenes. Trifluoroacetic acid was added to organ homogenates to achieve a pH of 2. The lysis solution was supplemented with Complete proteinase inhibitor and pepstatin (both Roche Diagnostics). Afterward, extracts were sonicated and centrifuged for 1 h at 50,000 x g. Supernatants were removed and passed through a Sephadex G-25 (Amersham Pharmacia, Freiburg, Germany) column. Low m.w. fractions were collected and passed through a SepPak C18 reversed-phase solid-phase extraction unit (Waters, Eschborn, Germany). Bound hydrophobic material was eluted, concentrated by vacuum centrifugation, and further fractionated by HPLC on a reversed-phase C18 column ({Delta} Pak C18-300A, 3.9 x 300 mm; Waters): 1 ml peptide extract was loaded and eluted with a flow rate of 1 ml/min on a linear acetonitrile gradient. Solution A, 0.1% trifluoroacetic acid; solution B, 70% acetonitrile, 0.09% trifluoroacetic acid. Gradient: 0- to 5-min 0% B, 5- to 55-min linear increase to 50% B; 55- to 63-min linear increase to 100% B; 63- to 66-min 100% B; 66- to 74-min linear decrease to 0% B. One-minute fractions were collected and stored at -70°C.

Isolation of naturally processed peptides from in vitro infected macrophage-like P388D1 (P388) cells was performed similarly. IFN-{gamma} pretreatment of P388 cells was performed for 24 h with 100 U/ml murine rIFN-{gamma} (R&D Systems). Approximately 1 x 108 adherent P388 cells were infected with L. monocytogenes at a multiplicity of infection of 10. After 1 h at 37°C, cells were washed once, and the medium was exchanged with medium containing 5 µg/ml gentamicin. After further 5-h incubation at 37°C, cells were washed twice with ice-cold PBS and were subsequently harvested with a cell scraper. Cell pellets were disrupted, sonicated, and lysed 30 min in 2 ml 0.5% trifluoroacetic acid supplemented with proteinase inhibitors, as described above. Subsequently, cell lysates were centrifuged for 30 min at 20,000 x g, and supernatants were further purified by ultrafiltration using Microsep (Pall-Gelman, Dreieich, Germany) ultrafiltration units with 10-kDa cutoff. The low m.w. fraction was further fractionated by HPLC, as described above.

Quantification of endogenously processed peptides

The precise amount of antigenic peptides in HPLC fractions was determined as described previously (15). Fractions were tested in a standard chromium release assay with 51Cr-labeled P815 cells as APC. The peptide concentration of the fractions was calculated by linear interpolation from lysis data obtained with a synthetic peptide standard. Recovery from spleen extracts was approximately 20% for p60217–225 and p60476–484, 10% for p60449–457, and 60% for LLO91–99. Recovery from cell extracts was ~20% for all three p60 peptides and 70% for LLO91–99. In the calculation of the total number of peptides per organ or per cell, the different recovery rates were counted.

ELISPOT-based Ag presentation assay

Ag presentation by in vivo infected cells was assessed with an ELISPOT-based Ag presentation assay, as described previously (15). This assay applies the basic principle of the ELISPOT assay for the detection of Ag presentation by target cells that acquired Ag in vivo. Splenocytes were used as APC after passing through nylon gaze (80 mesh) and RBC lysis. Alternatively, macrophages and DC isolated from infected spleens were used as APC. The ELISPOT assay was also used to detect antigenic material contained in HPLC fractions from peptide extracts. P815 cells were used as APC and were loaded with peptides, as described above. The setting of the assay was similar for all APC types. All APC were tested in the presence of 10 µg/ml gentamicin and 20 µg/ml tetracycline. In round-bottom 96-well microtiter plates, 3 x 104 peptide-specific CD8 T cells were added per well to graded numbers of APC in a final volume of 150 µl. After 5-h preincubation, cells were resuspended, and 100 µl cell suspension was transferred to rat anti-mouse IFN-{gamma} mAb-coated (RMMG-1; Biosource, Camarilla, CA) nylon membrane-backed 96-well microtiter plates (Nunc, Wiesbaden, Germany) and incubated overnight. ELISPOT plates were developed with biotin-labeled rat anti-mouse IFN-{gamma} mAb (clone XMG1.2; BD Biosciences, Heidelberg, Germany), HRP streptavidin conjugate (Dianova, Hamburg, Germany), and aminoethylcarbazole dye solution.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Effect of IFN-{gamma} on the generation of MHC class I-restricted antigenic peptides in vivo

To test the effect of IFN-{gamma} on the presentation of L. monocytogenes-derived antigenic peptides, a sensitive ELISPOT-based ex vivo Ag presentation assay was used (15). The ELISPOT-based Ag presentation assay is a qualitative way to assess Ag presentation by ex vivo isolated APCs. It is a highly sensitive alternative to other commonly used Ag presentation assays based on the quantification of cytokines, proliferation of responder cells, or killing of target cells. As other Ag presentation assays, the ELISPOT-based assay also is used for the direct comparison of different APC. GKO and wt mice were infected i.v. with 5 x 104 CFU L. monocytogenes, and 48 h postinfection (p.i.) splenocytes were tested with CD8 T cell lines specific for different CD8 T cell epitopes of L. monocytogenes. T cell activation was measured in an IFN-{gamma}-specific ELISPOT assay. Fig. 1Go shows the peptide presentation patterns of wt and GKO splenocytes. The strength of T cell activation, but not the activation pattern depended on the number of spleen cells present. On splenocytes of both wt and GKO mice, p60217–225 and LLO91–99 were the strongest peptides detected. In contrast to wt splenocytes that presented LLO91–99 stronger than p60217–225, the LLO91–99 epitope was presented weaker than p60217–225 on GKO splenocytes. Presentation of peptides p60449–457 and p60476–484 was also detected. While the presentation of p60476–484 remained constant in wt and GKO mice, the presentation of p60449–457 was stronger on GKO splenocytes compared with wt splenocytes. As a control, pp89168–176-specific CD8 T cells also were included that were not activated by L. monocytogenes-infected APC.



View larger version (24K):
[in this window]
[in a new window]
 
FIGURE 1. Different peptide presentation patterns in L. monocytogenes-infected wt and GKO mice. Mice were infected with 5 x 104 CFU L. monocytogenes. Ag presentation by spleen cells from infected wt mice or GKO mice was tested 48 h p.i. with a set of CD8 T cell lines in the ELISPOT-based Ag presentation assay. CD8 T cells specific for p60217–225, p60449–457, p60476–484, LLO91–99, or MCMV pp89168–176 were added to graded doses of splenocytes, as indicated. Shown is the total number of spots per 2 x 104 CD8 T cells. MCMV, murine CMV.

 
For the quantification of the effect of IFN-{gamma} on the generation of L. monocytogenes-derived CD8 T cell epitopes, naturally processed antigenic peptides were extracted from spleens of infected wt and GKO mice. BALB/c wt and GKO mice were infected i.v. with 1 x 106 and 1 x 104 CFU L. monocytogenes, respectively. These infectious doses were chosen to give similar bacterial loads in wt and GKO spleens 48 h after infection. Spleens were removed, and naturally processed antigenic peptides were extracted, separated by HPLC, and quantified. Fig. 2GoA shows the test of HPLC fractions from organ extracts with peptide-specific CD8 T cell lines in a 51Cr release assay. HPLC fractions 30/31 and 33/34 reacted with LLO91–99- and p60217–225-specific CD8 T cell lines, respectively. Peptides p60449–457 and p60476–484 were not detected by CD8 T cells of corresponding specificity (data not shown). The amount of p60217–225 and LLO91–99 peptide present in infected spleens was quantified by linear interpolation from an external peptide standard. Fig. 2GoB shows the number of extracted antigenic peptides per spleen for wt and GKO mice. Remarkably, in wt spleens, similar amounts of p60217–225 and LLO91–99 (ratio, 1.5) were detected, while GKO spleens yielded 30-fold less LLO91–99 peptide than p60217–225 peptide (ratio, 30). This difference of GKO and wt mice occurred in the presence of similar bacterial loads in spleen, which were 1.5 x 108 CFU and 1.2 x 108 CFU per spleen for wt and GKO mice, respectively.



View larger version (32K):
[in this window]
[in a new window]
 
FIGURE 2. IFN-{gamma} modulates the processing of L. monocytogenes-derived antigenic peptides in vivo. Naturally processed antigenic peptides were extracted and quantified from spleens of L. monocytogenes-infected wt and GKO mice 48 h after infection. A, After HPLC separation, fractions containing antigenic activity were identified in a 51Cr release assay with p60217–225- and LLO91–99-specific CD8 T cells, respectively. Shown is the percentage of the specific 51Cr release of P815 cells loaded with individual HPLC fractions. Arrows indicate the HPLC fraction in which LLO91–99 and p60217–225 elute. B, The total peptide content of positive fractions was determined by linear interpolation from a synthetic peptide standard. The total number of p60217–225 and LLO91–99 peptides per L. monocytogenes-infected spleen is shown for wt and GKO mice. C, Detection of antigenic peptides using the ELISPOT assay. P815 cells were loaded with the positive HPLC fractions, as described above. Bound antigenic peptides were detected with p60217–225- and LLO91–99-specific CD8 T cell lines in an IFN-{gamma}-specific ELISPOT assay. Shown is the number of spots per 2 x 105 T cells and 6.6 x 104 APC.

 
To correlate the results of the ELISPOT-based ex vivo Ag presentation assay with the data from the quantitative peptide extraction experiment, P815 cells loaded with a 1/32 dilution of the positive HPLC fractions 30 and 33 were also tested using the ELISPOT-based Ag presentation assay (Fig. 2GoC). The 20-fold difference of the peptide concentration of fraction 30 from wt and GKO spleen extracts resulted in an approximately 4-fold difference in the number of spots per well. Remarkably, the ELISPOT assay of HPLC fractions from peptide extracts yielded a qualitatively similar peptide presentation pattern as the direct ELISPOT-based analysis of splenocytes isolated from infected mice (see Fig. 1Go).

These results show that IFN-{gamma} influences the relative abundance of antigenic peptides in spleens, and thus changes the CD8 T cell recognition pattern of MHC class I-restricted antigenic peptides in L. monocytogenes-infected mice.

Effect of IFN-{gamma} on the presentation of MHC class I-restricted antigenic peptides by professional APC in vivo

Macrophages and DC are minor cell populations in the spleen, but both play a central role in the induction of a T cell response (20). For the direct ex vivo Ag presentation analysis of professional APC, cells expressing CD11c or CD11b were isolated by immunomagnetic separation from spleens of infected mice. Fig. 3Go shows the cytofluorometric analysis of cells freshly isolated by anti-CD11b- and anti-CD11c-coated magnetic microbeads, respectively. The CD11b+ cells were always CD11c-, indicating that no contamination with DC occurred. These anti-CD11b-selected, highly CD11b+ cells are further referred to as macrophages. A fraction of CD11c+ cells showed also low level CD11b expression, which is typical for myeloid DC (21). These highly CD11c+ cells are further referred to as DC. The Ag presentation pattern of these professional APC was tested qualitatively in the ELISPOT-based Ag presentation assay (Fig. 4Go). To eliminate variations due to changes of the sensitivity of T cell lines, the different APC types were always compared in the same experiment with the same set of T cell lines. The different peptide presentation patterns shown were confirmed in five independent experiments using different sets of CD8 T cell lines.



View larger version (24K):
[in this window]
[in a new window]
 
FIGURE 3. Ex vivo separation of professional APC from L. monocytogenes-infected mice. DC and macrophages were isolated by immunomagnetic separation from spleens of wt and GKO mice 48 h after infection with 5 x 104 CFU L. monocytogenes. The cytofluorometric analysis of ex vivo isolated macrophages (M{phi}) and DC is shown. Cells were stained with Abs of the indicated specificity (bold lines) or with isotype control Abs (thin lines).

 


View larger version (24K):
[in this window]
[in a new window]
 
FIGURE 4. MHC class I Ag presentation pattern on DC and macrophages isolated from L. monocytogenes-infected mice. DC and macrophages were isolated by immunomagnetic separation from spleens of wt or GKO mice 48 h p.i. with 5 x 104 CFU L. monocytogenes. Isolated DC, macrophages (M{phi}), or unseparated splenocytes were tested in the ELISPOT-based Ag presentation assay. The number of spots per 2 x 104 CD8 T cells and 3 x 104 APC per well is shown.

 
The comparison of these APC 48 h p.i. revealed similar Ag presentation patterns on DC, macrophages, and nonseparated spleen cells. However, compared with nonseparated spleen cells, DC and macrophages were recognized much more strongly (Fig. 4Go). The comparison of APC isolated from wt and GKO mice revealed different Ag presentation patterns. The strongest CD8 T cell epitope presented on DC and macrophages from L. monocytogenes-infected wt spleens was always LLO91–99, while p60217–225 was the strongest peptide presented on APC isolated from GKO mice.

These data demonstrate that the presentation pattern of CD8 T cell epitopes on professional APC is regulated by IFN-{gamma}.

Analysis of the processing of MHC class I-restricted antigenic peptides in vitro

The virulence and replication of L. monocytogenes differ strongly in wt and GKO mice. Because of the different growth kinetics of L. monocytogenes in wt and GKO mice, it was necessary to measure the presentation of one peptide in relation to other peptides. This approach detected that the relative abundance of p60217–225 and LLO91–99 in infected spleens and also the presentation of these epitopes on professional APC are IFN-{gamma} dependent. However, from these experiments, it could not be determined whether the absence of IFN-{gamma} results in reduced generation of LLO91–99, improved processing of p60217–225, or even both. The quantitative measurement of the absolute effect of IFN-{gamma} on the generation of naturally processed antigenic peptides is only possible if intracellular replication of bacteria is strictly controlled. This could only be achieved in an in vitro infection model.

Macrophage-like P388 cells were pretreated for 24 h with 100 U IFN-{gamma} and were subsequently infected with L. monocytogenes, and naturally processed antigenic peptides were extracted 6 h later. Plating of infected cells on blood agar revealed that IFN-{gamma} pretreatment did not significantly inhibit replication of bacteria during the 6-h infection phase (data not shown). The quantification of naturally processed p60217–225, p60449–457, and LLO91–99 peptides revealed that IFN-{gamma} had differential effects on peptide generation (Fig. 5GoA). The effect of IFN-{gamma} on the generation of different peptides was calculated as the ratio of peptides extracted in the presence and in the absence of IFN-{gamma} (Fig. 5GoB). IFN-{gamma} exerted only a minor effect on the generation of p60217–225, but it significantly inhibited the generation of p60449–457, and strongly promoted the processing of LLO91–99. Similar results were also obtained with J774 cells, another macrophage-like cell line (data not shown).



View larger version (18K):
[in this window]
[in a new window]
 
FIGURE 5. Effect of IFN-{gamma} on in vitro infected APC. Naturally processed antigenic peptides were extracted and quantified from L. monocytogenes-infected P388 cells. A, Before infection, P388 cells were pretreated for 24 h with 100 U/ml IFN-{gamma} ({blacksquare}) or left untreated ({square}). After HPLC separation, fractions containing antigenic activity were identified in a 51Cr release assay with p60217–225-, p60449–457-, and LLO91–99-specific CD8 T cells, respectively. The total peptide content of positive fractions was determined by linear interpolation from a synthetic peptide standard. Shown is the total number of naturally processed antigenic peptides per L. monocytogenes-infected cell from a representative experiment. B, The ratio of peptides (p60217–225, p60449–457, and LLO91–99) extracted from IFN-{gamma}-treated and untreated P388 cells was calculated. Shown are the means and SD from three independent experiments. The dotted line indicates a peptide ratio of 1.

 
These data show that IFN-{gamma} exerted differential, peptide-specific effects on peptide generation in vitro that correlated well with the peptide presentation patterns observed in wt and GKO mice.

Effect of IFN-{gamma} on the presentation of MHC class II-restricted antigenic peptides in vivo

To analyze the relevance of IFN-{gamma} for the presentation of MHC class II-restricted antigenic peptides in vivo, the peptide presentation pattern of a number of MHC class II-restricted T cell epitopes of L. monocytogenes was analyzed. Macrophages and DC were isolated from spleens of mice infected for 48 h. As the known immunodominant CD4 T cell epitopes of L. monocytogenes are Ab restricted (22), this study was performed with SV129 wt and IFN-{gamma} receptor-deficient RKO mice that possess the H-2b MHC haplotype. The presentation of the MHC class II Ab-restricted epitopes LLO190–201, LLO318–329, LLO253–264, and p60177–188 was analyzed qualitatively with the ELISPOT-based ex vivo Ag presentation assay using peptide-specific CD4 T lines to detect the presentation of specific peptides by professional APC (Fig. 6Go). Macrophages and DC isolated 48 h after infection with 1 x 104 CFU revealed similar Ag presentation patterns of CD4 T cell epitopes. The strongest peptide presented on both cell types was LLO190–201. The second strongest peptide presented on DC was p60177–188. The second strongest peptide presented on wt macrophages was LLO253–264. The peptide presentation pattern of DC from wt mice (LLO190–201 > p60177–199 > LLO318–329 = LLO253–264) was similar on DC isolated from RKO mice (Fig. 6Go, left). Compared with the Ag presentation pattern of macrophages from wt mice (LLO190–201 > LLO 253–264 > p60177–199 = LLO318–329), macrophages isolated from RKO mice revealed weaker presentation of LLO 253–264 (Fig. 6Go, right). However, presentation of LLO 253–264, p60177–199, and LLO318–329 was generally weak on macrophages, and the observed small differences between these peptides were not constant. The general Ag presentation pattern of CD4 T cell epitopes was observed in three independent experiments. Generally, the overall strength of Ag presentation was reduced on DC and macrophages isolated from infected RKO mice. In summary, these results demonstrate that despite the fact that presentation of L. monocytogenes-derived CD4 T cell epitopes by professional APC in vivo was enhanced by IFN-{gamma}, it was not generally required for efficient MHC class II-restricted Ag presentation, and also did not change the presentation pattern of different CD4 T cell epitopes.



View larger version (15K):
[in this window]
[in a new window]
 
FIGURE 6. Effect of IFN-{gamma} on MHC class II Ag presentation in vivo. The Ag presentation of L. monocytogenes-derived CD4 T cell epitopes was measured in the ELISPOT-based Ag presentation assay. DC and macrophages were isolated by immunomagnetic separation from spleens of L. monocytogenes-infected wt or GKO mice 48 h p.i. with 1 x 104 CFU L. monocytogenes. Isolated DC and macrophages (M{phi}) were tested with CD4 T cell lines of the indicated specificity. The number of spots per 2 x 104 CD8 T cells and 3 x 104 APC per well is shown.

 
Up-regulation of MHC class I and II expression after L. monocytogenes infection

Remarkably, strong presentation of CD4 T cell epitopes on macrophages and DC occurred in the absence of IFN-{gamma}. To investigate the effect of IFN-{gamma} on the general MHC expression level, a cytofluorometric analysis of MHC class I and MHC class II expression was performed. DC were isolated either from naive SV 129 wt and RKO mice or 48 h after L. monocytogenes infection (Fig. 7Go). Generally, MHC class I and II expression was stronger on APC from wt compared with RKO mice. However, remarkably, a significant up-regulation of MHC class II expression occurred also after infection of RKO mice, indicating that up-regulation of MHC expression is at least in part IFN-{gamma} independent.



View larger version (16K):
[in this window]
[in a new window]
 
FIGURE 7. Up-regulation of MHC class I and II expression on DC after L. monocytogenes infection. The cytofluorometric analysis of MHC class I and II expression was performed after immunomagnetic isolation of DC from spleens of L. monocytogenes-infected wt or GKO mice. Cells were isolated 48 h after i.v. infection with 1 x 104 CFU L. monocytogenes ({blacksquare}) or from noninfected mice ({square}). Isolated DC were stained with MHC class I- and II-specific mAb, respectively. Shown is the geometric mean fluorescence of gated CD11c+ cells.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The combination of immunomagnetic separation with a sensitive ELISPOT-based Ag presentation assay allowed the direct qualitative analysis of DC and macrophages that present Ag acquired in vivo during a bacterial infection. With L. monocytogenes-specific CD4 and CD8 T cell lines, the presentation of both MHC class I- and MHC II-restricted antigenic peptides could be studied. This type of analysis is not possible with the classical acidic extraction procedure (23) that requires higher numbers of infected cells and is generally limited to MHC class I-presented antigenic peptides. Because the number of peptide/MHC ligands required for T cell activation depends on the affinity of the TCR (24), the number of activated T cells in the ELISPOT-based Ag presentation assay is a qualitative measure for Ag presentation that does not directly reflect the absolute or relative numbers of extractable peptides present on an APC. The ex vivo analysis of professional APC demonstrated that DC and macrophages present L. monocytogenes-derived CD4 and CD8 T cell epitopes in vivo. It is currently believed that a significant part of bacterial and viral Ag presented by DC is acquired from apoptotic infected cells (25, 26). The analysis of DC infected with L. monocytogenes in vitro revealed that DC become rapidly apoptotic (27). A preliminary analysis of DC isolated from L. monocytogenes-infected mice could not detect intracellular bacteria by staining, and also revealed an excellent viability of isolated DC and macrophages (M. Skoberne and G. Geginat, unpublished observation), suggesting that these isolated cells were not infected by L. monocytogenes in vivo, but acquired the presented Ag either directly by phagocytosis of killed bacteria or by the uptake of fragments of infected apoptotic cells.

The stability of MHC class I/peptide complexes strongly influences the abundance of naturally processed antigenic peptides in L. monocytogenes-infected cells if the supply of Ag is limited (28). LLO91–99 and p60217–225 form relatively stable peptide/Kd complexes with a t1/2 of approximately 6 h, while p60449–457/Kd complexes have a t1/2 of less than 1 h (28, 29). Thus, the peptide presentation pattern of CD8 T cell epitopes, i.e., strong presentation of LLO91–99 and p60217–225 and weak presentation of p60449–457, reflects the stability of peptide/MHC class I complexes. The same Ag presentation pattern was also obtained with macrophages and unseparated spleen cells in the current and also a previous study (15), suggesting that presentation of L. monocytogenes-derived CD8 T cell epitopes by all important APC populations occurs under conditions in which the supply of Ag is limiting.

The analysis of L. monocytogenes-infected spleens showed that IFN-{gamma} had only a peptide-specific influence on the presentation pattern of CD8 T cell epitopes in vivo, and that the lack of IFN-{gamma} was not generally accompanied with reduced MHC class I-restricted Ag presentation. Previously, it was shown that IFN-{gamma} has a general enhancing effect on MHC class I- and MHC class II-restricted Ag presentation by L. monocytogenes-infected macrophages in vitro (30). A general enhancing effect of IFN-{gamma} on Ag presentation has been shown also in an in vivo study of mice infected with the murine CMV (31).

IFN-{gamma} modulates the presentation of CD8 T cell epitopes by a number of different mechanisms. It modulates the cleavage preferences of the proteasome, influences the TAP-mediated transport of antigenic peptides, and also up-regulates the expression of MHC class I molecules (9, 10, 11). The analysis of the effect of IFN-{gamma} on the processing and presentation of different L. monocytogenes-derived peptides in vivo revealed that it improved processing of one peptide (LLO91–99), reduced processing of another (e.g., p60449–457), or had no effect at all (p60217–225). These differential, peptide-specific effects of IFN-{gamma} on Ag processing in vitro correlate with the effect of IFN-{gamma} in vivo. The changed cleavage specificity of the IFN-{gamma} -inducible immunoproteasome provides a possible explanation for these IFN-{gamma}-mediated, peptide-specific effects on the Ag presentation pattern (32, 33, 34, 35, 36). Dependent on the sequence of the epitope itself and also its flanking sequences, the changed cleavage specificity of the immunoproteasome could mediate differential effects on the processing of individual antigenic peptides.

Professional, bone marrow-dependent APC are required for the induction of a primary antilisterial CD8 T cell response (37). Thus, the IFN-{gamma}-mediated regulation of the peptide presentation pattern of DC and macrophages could influence the hierarchy of responding CD8 T cell populations. From studies of the murine L. monocytogenes (3, 8) and the lymphocytic choriomeningitis virus infection (38), it is known that IFN-{gamma} is not required to induce a specific CD8 T cell response and that the infection of GKO mice even results in an enhanced peptide-specific CD8 T cell response. This apparently paradoxical situation could be due to a higher bacterial or viral load in GKO mice, as it is clearly the situation in lymphocytic choriomeningitis virus-infected GKO mice (38). The analysis of the hierarchy of T cell populations in GKO and wt mice showed a changed immunodominance pattern of LLO91–99- and p60217–225-specific CD8 T cell populations (8). While in wt mice LLO91–99-specific CD8 T cells outnumbered p60217–225-specific cells in a 5:1 ratio, in GKO mice p60217–225- and LLO91–99-specific CD8 T cells were present in a 2:1 ratio. Remarkably, this change of the immunodominance pattern of antilisterial CD8 T cell populations correlates with the observed effect of IFN-{gamma} on the peptide presentation pattern of ex vivo isolated DC and macrophages.

In contrast to the CD8 T cell epitopes, no strong influence of IFN-{gamma} on the peptide presentation pattern of CD4 T cell epitopes was observed. However, presentation of CD4 T cell epitopes was generally weaker in RKO mice. This effect correlated with a generally reduced MHC class II expression level on APC from RKO mice. Remarkably, the up-regulation of MHC class II molecules after infection occurred also in RKO mice, suggesting that IFN-{gamma}-independent up-regulation of MHC molecules might act compensatory in RKO mice.

The stability of MHC class II/peptide complexes of L. monocytogenes-derived CD4 T cell epitopes is currently unknown. However, similar to the CD8 T cell epitopes, the presentation of CD4 T cell epitopes also showed a typical peptide presentation pattern. LLO190–201 was always the strongest peptide detected on DC and macrophages. This epitope is also the immunodominant CD4 T cell epitope in L. monocytogenes-infected C57BL/6 mice (22). Thus, a similar correlation exists as for CD8 T cell epitopes, in which the immunodominant CD8 T cell populations are directed against the most stable epitopes that are most abundant in vivo (15).

In summary, these results show that despite IFN-{gamma} modulation of the Ag presentation pattern of CD8 T cell epitopes, IFN-{gamma} is not generally required for the MHC class I- and MHC class II-restricted presentation of L. monocytogenes-derived antigenic peptides by professional APC in vivo. Considering the multiple steps of Ag processing and presentation influenced by IFN-{gamma}, this is an unexpected result. The constitutive ability of macrophages and DC to efficiently process and present Ags highlights the functional properties of these dedicated APC. The full appreciation of these functional properties requires further detailed analysis on how professional APC acquire and process Ags in vivo.


    Acknowledgments
 
We thank S. Schenk for excellent technical assistance, D. Schlüter for providing GKO mice, and R. Holtappels (University of Mainz) for providing the pp89168–176-specific CD8 T cell line.


    Footnotes
 
1 This work was supported by Deutsche Forschungsgemeinschaft Grant GE 1081/1-1. M.. was supported by the Slovenian Ministry of Science and the Medical Faculty of the University of Ljubljana. Back

2 Address correspondence and reprint requests to Dr. Gernot Geginat, Institut für Medizinische Mikrobiologie und Hygiene, Fakultät für Klinische Medizin Mannheim der Universität Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany. E-mail address: geginat{at}rumms.uni-mannheim.de Back

3 Abbreviations used in this paper: GKO, IFN-{gamma} knockout; DC, dendritic cell; LLO, listeriolysin O; p.i., postinfection; RKO, IFN-{gamma} receptor knockout; wt, wild type. Back

Received for publication October 11, 2001. Accepted for publication December 7, 2001.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Boehm, U., T. Klamp, M. Groot, J. C. Howard. 1997. Cellular responses to interferon-{gamma}. Annu. Rev. Immunol. 15:749.[Medline]
  2. Poston, R. M., R. J. Kurlander. 1991. Analysis of the time course of IFN-{gamma} mRNA and protein production during primary murine listeriosis: the immune phase of bacterial elimination is not temporally linked to IFN production in vivo. J. Immunol. 146:4333.[Abstract]
  3. Harty, J. T., M. J. Bevan. 1995. Specific immunity to Listeria monocytogenes in the absence of IFN {gamma}. Immunity 3:109.[Medline]
  4. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R. M. Zinkernagel, M. Aguet. 1993. Immune response in mice that lack the interferon-{gamma} receptor. Science 259:1742.[Abstract/Free Full Text]
  5. Leenen, P. J., B. P. Canono, D. A. Drevets, J. S. Voerman, P. A. Campbell. 1994. TNF-{alpha} and IFN-{gamma} stimulate a macrophage precursor cell line to kill Listeria monocytogenes in a nitric oxide-independent manner. J. Immunol. 153:5141.[Abstract]
  6. Van Dissel, J. T., J. J. Stikkelbroeck, R. van Furth. 1993. Differences in the rate of intracellular killing of catalase-negative and catalase-positive Listeria monocytogenes by normal and interferon-{gamma}-activated macrophages. Scand. J. Immunol. 37:443.[Medline]
  7. Peck, R.. 1989. {gamma} Interferon induces monocyte killing of Listeria monocytogenes by an oxygen-dependent pathway; {alpha}- or {beta}-interferons by oxygen-independent pathways. J. Leukocyte Biol. 46:434.[Abstract]
  8. Badovinac, V. P., A. R. Tvinnereim, J. T. Harty. 2000. Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferon-{gamma}. Science 290:1354.[Abstract/Free Full Text]
  9. Epperson, D. E., D. Arnold, T. Spies, P. Cresswell, J. S. Pober, D. R. Johnson. 1992. Cytokines increase transporter in antigen processing-1 expression more rapidly than HLA class I expression in endothelial cells. J. Immunol. 149:3297.[Abstract]
  10. Groettrup, M., A. Soza, U. Kuckelkorn, P. M. Kloetzel. 1996. Peptide antigen production by the proteasome: complexity provides efficiency. Immunol. Today 17:429.[Medline]
  11. David Watine, B., A. Israel, P. Kourilsky. 1990. The regulation and expression of MHC class I genes. Immunol. Today 11:286.[Medline]
  12. Lafuse, W. P., D. Brown, L. Castle, B. S. Zwilling. 1995. IFN-{gamma} increases cathepsin H mRNA levels in mouse macrophages. J. Leukocyte Biol. 57:663.[Abstract]
  13. Lah, T. T., M. Hawley, K. L. Rock, A. L. Goldberg. 1995. {gamma}-Interferon causes a selective induction of the lysosomal proteases, cathepsins B and L, in macrophages. FEBS Lett. 363:85.[Medline]
  14. Mach, B., V. Steimle, E. Martinez-Soria, W. Reith. 1996. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14:301.[Medline]
  15. Skoberne, M., R. Holtappels, H. Hof, G. Geginat. 2001. Dynamic antigen-presentation patterns of Listeria monocytogenes-derived CD8 T cell epitopes in vivo. J. Immunol. 167:2209.[Abstract/Free Full Text]
  16. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-{gamma} genes. Science 259:1739.[Abstract/Free Full Text]
  17. Holtappels, R., J. Podlech, G. Geginat, H. P. Steffens, D. Thomas, M. J. Reddehase. 1998. Control of murine cytomegalovirus in the lungs: relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral cytolytic T-lymphocyte response in pulmonary infiltrates. J. Virol. 72:7201.[Abstract/Free Full Text]
  18. Azuma, M., H. Yssel, J. H. Phillips, H. Spits, L. L. Lanier. 1993. Functional expression of B7/BB1 on activated T lymphocytes. J. Exp. Med. 177:845.[Abstract/Free Full Text]
  19. Geginat, G., M. Kretschmar, S. Walter, D. Junker, H. Hof, T. Nichterlein. 1999. Suppression of acquired immunity against Listeria monocytogenes by amphotericin B-mediated inhibition of CD8 T cell function. J. Infect. Dis. 180:1186.[Medline]
  20. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767.[Medline]
  21. Vremec, D., K. Shortman. 1997. Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J. Immunol. 159:565.[Abstract]
  22. Geginat, G., S. Schenk, M. Skoberne, W. Goebel, H. Hof. 2001. A novel approach of direct ex vivo epitope mapping identifies dominant and subdominant CD4 and CD8 T cell epitopes from Listeria monocytogenes. J. Immunol. 166:1877.[Abstract/Free Full Text]
  23. Falk, K., O. Rötzschke, K. Deres, J. Metzger, G. Jung, H. G. Rammensee. 1991. Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast. J. Exp. Med. 174:425.[Abstract/Free Full Text]
  24. Schodin, B. A., T. J. Tsomides, D. M. Kranz. 1996. Correlation between the number of T cell receptors required for T cell activation and TCR-ligand affinity. Immunity 5:137.[Medline]
  25. Albert, M. L., B. Sauter, N. Bhardwaj. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392:86.[Medline]
  26. Yrlid, U., M. J. Wick. 2000. Salmonella-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells. J. Exp. Med. 191:613.[Abstract/Free Full Text]
  27. Guzman, C. A., E. Domann, M. Rohde, D. Bruder, A. Darji, S. Weiss, J. Wehland, T. Chakraborty, K. N. Timmis. 1996. Apoptosis of mouse dendritic cells is triggered by listeriolysin, the major virulence determinant of Listeria monocytogenes. Mol. Microbiol. 20:119.[Medline]
  28. Sijts, A. J., E. G. Pamer. 1997. Enhanced intracellular dissociation of major histocompatibility complex class I-associated peptides: a mechanism for optimizing the spectrum of cell surface-presented cytotoxic T lymphocyte epitopes. J. Exp. Med. 185:1403.[Abstract/Free Full Text]
  29. Busch, D. H., E. G. Pamer. 1998. MHC class I/peptide stability: implications for immunodominance, in vitro proliferation, and diversity of responding CTL. J. Immunol. 160:4441.[Abstract/Free Full Text]
  30. Hiltbold, E. M., H. K. Ziegler. 1996. Interferon-{gamma} and interleukin-10 have cross-regulatory roles in modulating the class I and class II MHC-mediated presentation of epitopes of Listeria monocytogenes by infected macrophages. J. Interferon Cytokine Res. 16:547.[Medline]
  31. Geginat, G., T. Ruppert, H. Hengel, R. Holtappels, U. H. Koszinowski. 1997. IFN-{gamma} is a prerequisite for optimal antigen processing of viral peptides in vivo. J. Immunol. 158:3303.[Abstract]
  32. Boes, B., H. Hengel, T. Ruppert, G. Multhaup, U. H. Koszinowski, P. M. Kloetzel. 1994. Interferon {gamma} stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes. J. Exp. Med. 179:901.[Abstract/Free Full Text]
  33. Gaczynska, M., K. L. Rock, A. L. Goldberg. 1993. {gamma}-Interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 365:264.[Medline]
  34. Ustrell, V., G. Pratt, M. Rechsteiner. 1995. Effects of interferon {gamma} and major histocompatibility complex-encoded subunits on peptidase activities of human multicatalytic proteases. Proc. Natl. Acad. Sci. USA 92:584.[Abstract/Free Full Text]
  35. Sijts, A. J., T. Ruppert, B. Rehermann, M. Schmidt, U. Koszinowski, P. M. Kloetzel. 2000. Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes. J. Exp. Med. 191:503.[Abstract/Free Full Text]
  36. Sijts, A. J., S. Standera, R. E. Toes, T. Ruppert, N. J. Beekman, P. A. van Veelen, F. A. Ossendorp, C. J. Melief, P. M. Kloetzel. 2000. MHC class I antigen processing of an adenovirus CTL epitope is linked to the levels of immunoproteasomes in infected cells. J. Immunol. 164:4500.[Abstract/Free Full Text]
  37. Lenz, L. L., E. A. Butz, M. J. Bevan. 2000. Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens. J. Exp. Med. 192:1135.[Abstract/Free Full Text]
  38. Bartholdy, C., J. P. Christensen, D. Wodarz, A. R. Thomsen. 2000. Persistent virus infection despite chronic cytotoxic T-lymphocyte activation in {gamma} interferon-deficient mice infected with lymphocytic choriomeningitis virus. J. Virol. 74:10304.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Immunol.Home page
K. A. N. Messingham, V. P. Badovinac, A. Jabbari, and J. T. Harty
A Role for IFN-{gamma} from Antigen-Specific CD8+ T Cells in Protective Immunity to Listeria monocytogenes
J. Immunol., August 15, 2007; 179(4): 2457 - 2466.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. R. Kollmann, B. Reikie, D. Blimkie, S. S. Way, A. M. Hajjar, K. Arispe, A. Shaulov, and C. B. Wilson
Induction of Protective Immunity to Listeria monocytogenes in Neonates
J. Immunol., March 15, 2007; 178(6): 3695 - 3701.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Skoberne, S. Schenk, H. Hof, and G. Geginat
Cross-Presentation of Listeria monocytogenes-Derived CD4 T Cell Epitopes
J. Immunol., August 1, 2002; 169(3): 1410 - 1418.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Skoberne, M.
Right arrow Articles by Geginat, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Skoberne, M.
Right arrow Articles by Geginat, G.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS